Viridian Therapeutics, Inc.\DE (VRDN) Operating margin 2016–2025
Viridian Therapeutics, Inc.\DE (VRDN) operating margin by fiscal year — reported operating income divided by reported revenue.
-512.9%FY2025 · since FY2016: -488.6% → -512.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -512.9% | +98505.3 pp |
| FY2024 | -99018.2% | -17983.2 pp |
| FY2023 | -81035.0% | -73455.8 pp |
| FY2022 | -7579.2% | -4888.4 pp |
| FY2021 | -2690.8% | +7821.6 pp |
| FY2020 | -10512.4% | -9571.4 pp |
| FY2019 | -941.0% | -546.5 pp |
| FY2018 | -394.5% | +268.3 pp |
| FY2017 | -662.8% | -174.2 pp |
| FY2016 | -488.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice